Poland· PL-100490111
Jaypirca
A medicinal product containing pirtobrutinibum, registered in Poland by Eli Lilly Nederland B.V..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Pirtobrutinibum
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pirtobrutinibum in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJAYPIRCAEli Lilly Nederland B.V., Utrecht
- SwitzerlandJaypirca
- IrelandJaypirca 50 mg film-coated tabletsEli Lilly Nederland B.V.
- IcelandJaypircaEli Lilly Nederland B.V.*
- NetherlandsJaypirca 50 mg filmomhulde tablettenEli Lilly Nederland B.V.
- BelgiumJaypirca 50 mgEli Lilly Nederland
- SwedenJaypirca 50 mg Filmdragerad tablettEli Lilly Nederland B.V.
- FinlandJaypircaEli Lilly Nederland B.V
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jaypirca
- Liechtenstein · Jaypirca
- Norway · Jaypirca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c6fd2a7-ade0-4ec2-be00-ad0ba3e6b80e GET /v1/drugs/9c6fd2a7-ade0-4ec2-be00-ad0ba3e6b80e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg",
"packaging": "Rpz ¦ EU/1/23/1738/001 ¦ 152095\n28 tabl.\nRpz ¦ EU/1/23/1738/002 ¦ 152096\n30 tabl.\nRpz ¦ EU/1/23/1738/003 ¦ 152097\n84 tabl.",
"substance": "Pirtobrutinibum 50 mg",
"common_name": "Pirtobrutinibum",
"pl_product_id": "100490111",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about pirtobrutinibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.